Journal of Diabetes Research / 2012 / Article / Tab 4

Review Article

Cellular Dysfunction in Diabetes as Maladaptive Response to Mitochondrial Oxidative Stress

Table 4

Effect of diabetes in protein carbonyl content (PCC) levels from human tissues.

TissueModel/conditionEffectReference

ErythrocytesObese type 2 diabetic patients[46]
ErythrocytesType 2 diabetic patients versus healthy subjects[47]
Erythrocyte membraneType 2 diabetic patients versus healthy subjects[48]
LymphocytesType 2 diabetic patients versus age-matched controls[49]
LymphocytesDM patients versus healthy subjects[50]
PlacentaWomen with gestational diabetes versus healthy pregnant women[51]
Plasma proteinsType 2 diabetic patients versus healthy subjects=[52]
Plasma proteinsDialysis patients versus control subjects[53]
Plasma proteinsDiabetic type 2 patients versus healthy subjects[54]
Plasma proteinsType 1 diabetes without complications[55]
Plasma proteinsType 1 diabetes with complications[55]
Plasma proteinsChronic kidney disease patients versus healthy subjects[56]
Plasma proteinsDiabetes type 2 versus healthy subjects[57]
Plasma proteinsDiabetes type 2 associated with CVD versus healthy subjects[57]
Plasma proteinsGood glycemic control versus poor glycemic control[58]
Plasma proteinsType 1 diabetic patients=[59]
Plasma proteinsEnd-stage renal disease[59]
Plasma proteinsHeart failure + diabetes versus healthy subjects[60]
Plasma proteinsType 2 diabetes without microangiopathy versus healthy subjects[61]
Plasma proteinsType 2 diabetes with microangiopathy versus healthy subjects[61]
Plasma proteinsType 2 diabetic patients versus age-matched controls[49]
Plasma proteinsChildhood type 1 diabetes[62]
Plasma proteinsDiabetic patients without ulcer versus healthy subjects[63]
Plasma proteinsDiabetic patients with foot ulcer grade 1 versus healthy subjects[63]
Plasma proteinsDiabetic patients with foot ulcer grade 2 versus healthy subjects[63]
Plasma proteinsDiabetic patients versus healthy subjects[64]
Plasma proteinsIGT subjects versus healthy subjects[64]
Plasma proteinsDiabetic type 2 patients versus healthy subjects[65]
PlateletsType 2 diabetes (young versus elderly)[66]
SerumType 1 diabetic patients versus healthy subjects[67]
SerumDiabetic patients versus healthy subjects[68]
SerumDiabetic nephropathy patients versus healthy subjects[68]
Skin collagenType 2 diabetes[69]
Subretinal fluidDiabetic patients versus control subjects[70]

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.